Latest Regulatory News

Clarity Pharmaceuticals has successfully completed recruitment for its pivotal Co-PSMA Phase II trial, testing its novel Cu-SAR-bisPSMA diagnostic against the current standard in detecting prostate cancer recurrence. This milestone advances their mission to improve early detection and treatment outcomes for men with low PSA levels.

Nova Minerals has closed a US$11.1 million underwritten offering on NASDAQ, positioning itself to advance exploration and feasibility studies at its Estelle Gold and Critical Minerals Project in Alaska.

Locksley Resources has confirmed multiple new mineralised trends at its Mojave Critical Minerals Project in California, setting the stage for an expanded drilling campaign in Q3 2025. The company’s detailed structural mapping and 3D geological modelling have refined exploration targets for antimony and rare earth elements, aligning with growing US strategic interests in domestic critical minerals.

Little Green Pharma reported a robust June 2025 quarter with record cash receipts and expanding European footprint, highlighted by a new production capacity in Denmark and the launch of its CherryCo brand in Germany.

Agrimin Limited's associate, Tali Resources, officially lists on the ASX with Agrimin holding a significant 27% stake following a fully subscribed $2 million priority offer.

Osmond Resources has verified monazite as the dominant rare earth mineral at its Orión Project in Spain, highlighting elevated levels of critical magnetic rare earth elements. A maiden drilling program and ongoing metallurgical testing aim to advance the project as a strategic EU supply source.

Ionic Rare Earths’ Brazilian joint venture Viridion has secured land and government backing to build South America’s inaugural rare earth refining and recycling centre, aiming to start operations by late 2026.

IDT Australia has signed a memorandum with NASDAQ-listed Gelteq to establish a dedicated gel-based product manufacturing facility, marking a strategic expansion in pharmaceutical delivery technologies.

Immuron Limited reports a robust 49% increase in FY25 global sales of its immune supplement Travelan, driven by strong growth in Australia and North America. The company plans to accelerate its North American market presence in FY26.

FireFly Metals reports exceptional infill drilling results at its Green Bay Copper-Gold Project, confirming strong mineral continuity and setting the stage for a resource upgrade and mining feasibility studies.

Buru Energy revises its Rafael Gas Project development plan, prioritising drilling the Rafael B appraisal well in mid-2026 and delaying the Final Investment Decision by six months, while maintaining first production for late 2027.

Great Boulder Resources has released a scoping study for its Ironbark deposit within the Side Well Gold Project, highlighting a high-grade 100,000 oz resource and strong financial metrics that underpin a promising mining opportunity near Meekatharra, WA.